Symposium Summary: Expanding Horizons in NIPT – From Aneuploidy to Single-Gene Disorders

As part of our ongoing education series for OBGYNs on the evolution of Non-Invasive Prenatal Testing (NIPT), we successfully hosted the symposium “Expanding Horizons in NIPT – From Aneuploidy to Single-Gene Disorders” on 29 November 2025 in Kuala Lumpur, Malaysia.

A heartfelt thank you to all the healthcare professionals who joined us.
We were delighted to welcome nearly 200 participants, both onsite and online, including attendees from Indonesia, India, Taiwan, Singapore and Brunei.

Organised by Gene Solutions, and proudly supported by the Obstetrical and Gynaecological Society of Malaysia (OGSM) and the Malaysian Medical Association (MMA), the session brought together Consultant O&G and MFM specialists, a Clinical Geneticist & Consultant Paediatrician, and the Medical Director from Gene Solutions to share and discuss the latest advances in prenatal screening.

✨ Key Highlights from the Session

+ Beyond Aneuploidy — The evolution of NIPT through the integration of carrier screening and dominant single-gene disorder screening into NIPT.

+ Counselling as a Core Component — Clear communication drives informed decision-making.

+ Broader Clinical Value — Integrating recessive & dominant conditions for comprehensive prenatal insights.

+ Technology Enhancing Accuracy — NGS and AI-powered analytics enabling deeper, more reliable results.

Thank you for the strong regional support. We look forward to more collaborative learning ahead!

About Gene Solutions Malaysia
Established in 2023, Gene Solutions Malaysia is part of Gene Solutions, a global biotechnology company headquartered in Singapore and dedicated to making advanced genomic solutions more accessible and affordable.

We provide genomic testing and precision healthcare solutions across oncology, reproductive health and women’s health, leveraging Next-Generation Sequencing (NGS), multi-omics and Artificial Intelligence (AI).

The company offers a comprehensive portfolio across oncology, including early cancer screening (SPOT-MAS CRC, SPOT-MAS Lung), multi-cancer early detection (SPOT-MAS 10), and precision oncology (K-TRACK, K4CARE), as well as reproductive and women’s health solutions, including non-invasive prenatal testing (TriSure) and gynecologic cancer screening and triage (SPOT-MAS Eva, EpiHera).

Through collaborations with hospitals, healthcare institutions, laboratories and medical professionals across Malaysia, we are working to bring innovative genomic solutions into clinical practice and contribute to the advancement of precision medicine.